Stockscreener 앱 받기
4.52
1.74%
-0.08
시장 영업 전:
4.54
0.02
+0.44%
Onkure Therapeutics Inc 주식(OKUR)의 최신 뉴스
[10-Q] OnKure Therapeutics, Inc. Quarterly Earnings Report - Stock Titan
OnKure (Nasdaq: OKUR) lifts cash to $192.1 million after raise - Stock Titan
OnKure bets on 2 PI3K drugs for breast cancer and vascular anomalies - Stock Titan
OnKure Therapeutics Reports First Quarter 2026 Financial Results - Yahoo! Finance Canada
[EFFECT] OnKure Therapeutics, Inc. SEC Filing - Stock Titan
Aclarion reports cash runway to ops into late 2027 - BizWest
OnKure Therapeutics (OKUR) price target decreased by 15.13% to 20.60 - MSN
OnKure Therapeutics (OKUR) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
OnKure Therapeutics prices $150M oversubscribed private placement - MSN
What top holdings OnKure Therapeutics (OKUR)? (Smart Money Active) 2026-04-27Earnings Beat Stocks - Newser
OKUR (OnKure Therapeutics) reports narrower Q4 2025 loss than estimates, shares drop 2.04 percent in trading. - Newser
Short Interest in OnKure Therapeutics, Inc. (NASDAQ:OKUR) Drops By 57.6% - MarketBeat
OnKure Therapeutics (OKUR) Price Target Decreased by 10.00% to 27.54 - MSN
OnKure Therapeutics (NASDAQ: OKUR) registers 36.1M shares for resale - Stock Titan
[DEF 14A] OnKure Therapeutics, Inc. Definitive Proxy Statement - Stock Titan
OnKure Therapeutics (OKUR) Stock Bollinger Bands (Risk Aversion) 2026-04-20Small Cap Breakout - Xã Thanh Hà
OnKure Therapeutics (OKUR) Stock Opening VWAP (Spikes) 2026-04-18Stock Distribution - Cổng thông tin điện tử tỉnh Lào Cai
What date does OnKure Therapeutics, Inc.'s (OKUR) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
Short Interest in OnKure Therapeutics, Inc. (NASDAQ:OKUR) Increases By 1,958.6% - MarketBeat
Revenue Check: Whats the profit margin of OnKure Therapeutics Inc2026 Volume Leaders & Growth-Oriented Investment Plans - baoquankhu1.vn
Growth Recap: Is Vistra Corp gaining market shareQuarterly Trade Summary & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
OKUR SEC FilingsOnKure Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Access Industries (OKUR) discloses 19.99% OnKure stake and board right - Stock Titan
StepStone affiliates report 2.66M shares in OnKure (NASDAQ: OKUR) - Stock Titan
RA Capital group reports 9.99% stake in OnKure (NASDAQ: OKUR) - Stock Titan
Trails Edge holds 6.0% of OnKure (NASDAQ: OKUR) after private placement - Stock Titan
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Trading Recap: Whats the profit margin of OnKure Therapeutics Inc2026 Biggest Moves & AI Driven Price Forecasts - baoquankhu1.vn
LifeSci Capital Maintains OnKure Therapeutics(OKUR.US) With Buy Rating, Cuts Target Price to $16 - 富途牛牛
Is OnKure Therapeutics (OKUR) Stock Safe to Buy Now | Price at $4.39, Up 2.33%Stock Idea Sharing Hub - UBND thành phố Hải Phòng
Breakouts Watch: Can OnKure Therapeutics Inc deliver consistent EPS growthDay Trade & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
OnKure (OKUR) CEO Nicholas Saccomano awarded 330,000 stock options - Stock Titan
OnKure (OKUR) CFO granted 110,000 stock options at $4.07 - Stock Titan
OnKure Therapeutics (OKUR) awards 110,000 options to Chief Scientific Officer - Stock Titan
OnKure (OKUR) grants CMO 110,000 stock options at $4.07 strike - Stock Titan
OnKure (OKUR) director receives 15,300 stock options at $4.14 strike price - Stock Titan
OnKure Therapeutics (OKUR) director Liam Ratcliffe submits Form 3 insider report - Stock Titan
Acorn funds and Anders Hove disclose stakes in OnKure (NASDAQ: OKUR) up to 9.5% - Stock Titan
OKUR Stock Analysis: OnKure Therapeutics Inc. Biotech 1.69% Dip at $4.07 Trading Level - Cổng thông tin điện tử tỉnh Tây Ninh
Leerink cuts OnKure stock price target on strategic shift By Investing.com - Investing.com Canada
Leerink cuts OnKure stock price target on strategic shift - investing.com
OnKure Announces $150M Private Placement and Board Changes - TipRanks
OnKure elects Dr. Liam Ratcliffe as director under Lead Investor designation - TradingView — Track All Markets
OnKure (NASDAQ: OKUR) secures $150M private placement and refocuses PI3Kα pipeline - Stock Titan
Panic Selling: Whats the profit margin of OnKure Therapeutics IncTake Profit & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
OnKure Therapeutics Sees Volatile Trading Amid Recent Developments - timothysykes.com
OKUR Shares Face Turbulence Amid Financial Downturn - StocksToTrade
OnKure Therapeutics Inc. Sees Variable Performance Amid Market Fluctuations - timothysykes.com
0.14%
0.48%
자본화:
|
볼륨(24시간):